{"id":266286,"date":"2026-02-10T19:15:15","date_gmt":"2026-02-10T18:15:15","guid":{"rendered":"https:\/\/www.wholecelium.com\/?p=266286"},"modified":"2026-02-10T19:15:18","modified_gmt":"2026-02-10T18:15:18","slug":"could-psilocybin-help-treat-obesity-diabetes-and-fatty-liver-disease","status":"publish","type":"post","link":"https:\/\/www.wholecelium.com\/ro\/blog\/could-psilocybin-help-treat-obesity-diabetes-and-fatty-liver-disease\/","title":{"rendered":"Could Psilocybin Help Treat Obesity, Diabetes, and Fatty Liver Disease?"},"content":{"rendered":"

New research suggests magic mushrooms may influence metabolism far beyond the brain<\/strong><\/h2>\n\n\n\n

For years, the idea of psychedelics treating obesity has sounded\u2026 unconventional, to say the least. These compounds are best known for altering consciousness, reshaping perception, and catalyzing psychological insight \u2014 not regulating blood sugar or repairing fatty livers.<\/strong><\/p>\n\n\n\n

But a growing body of research is quietly expanding that narrative. While earlier theories focused on psychedelics \u201crewiring\u201d compulsive eating behaviors in the brain, new preclinical findings suggest psilocybin may also work outside the mind entirely<\/strong>, acting directly on metabolic organs like the liver, muscle, and pancreas.<\/p>\n\n\n\n

Together, these findings point to a surprising possibility. Psilocybin\u2019s therapeutic potential may extend well beyond mental health, into the realm of obesity, type 2 diabetes, and metabolic disease<\/strong>.<\/p>\n\n\n\n

Obesity Is More Than Calories In, Calories Out<\/h3>\n\n\n\n

Obesity is a complex, chronic condition marked by excessive fat accumulation and metabolic dysfunction. While diet, physical activity, genetics, and environment all play key roles, researchers increasingly recognize that obesity isn\u2019t a single disease \u2014 it\u2019s a constellation of biological and behavioral patterns.<\/p>\n\n\n\n

For some people, overeating resembles addictive behavior<\/strong>. Highly palatable foods can hijack the brain\u2019s reward system, driving compulsive consumption despite negative consequences. In these cases, food cues trigger powerful cravings that are difficult to override, even with strong motivation.<\/p>\n\n\n\n

Researchers have used tools like the Yale Food Addiction Scale<\/a><\/strong> to identify individuals whose eating patterns closely resemble substance-use disorders. The implication? Treatments that work for addiction might also help certain forms of obesity.<\/p>\n\n\n\n

\"\"
The chemical symbol for Psilocybin<\/mark><\/em><\/figcaption><\/figure>\n\n\n\n

The Early Psychedelic Hypothesis: Changing the Brain<\/h4>\n\n\n\n

This idea formed the basis of a recent review published in the Journal of Eating Disorders<\/em>. In it, researchers from the University of Oxford explored whether psychedelics could offer a novel therapeutic pathway for obesity linked to compulsive eating.<\/p>\n\n\n\n

Classic psychedelics like psilocybin, LSD, and ayahuasca primarily act on serotonin receptors (especially the Receptorul 5-HT2A<\/strong>)<\/em> which plays a central role in perception, cognition, and emotional processing. These compounds are also known to promote neuroplasticitate<\/a><\/strong>, the brain\u2019s ability to form new connections and revise deeply ingrained habits.<\/p>\n\n\n\n

In addiction studies, psychedelics have been shown to enhance the effects of psychotherapy, helping people loosen rigid behavioral patterns and make lasting changes. One prominent framework, the REBUS model<\/strong> (Convingeri relaxate sub psihedelice)<\/em>, suggests that psychedelics temporarily soften entrenched mental predictions. This creates a window where new behaviors can take root.<\/p>\n\n\n\n

Applied to eating behavior, this could mean weakening the automatic link between food cues and consumption. Thus allowing individuals to relate to food in a more flexible, intentional way.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n
A New Twist: Psilocybin Without the Psychedelic Effect<\/h5>\n\n\n\n

While this brain-based theory is compelling, a new preclinical study<\/strong> adds an unexpected layer to the story.<\/p>\n\n\n\n

Published in Pharmacological Research<\/a><\/em>, researchers from two Italian universities, along with collaborators across Europe and the United States, investigated whether very low doses of psilocybin<\/strong> could improve metabolic health \u2014 without producing psychedelic effects.<\/p>\n\n\n\n

In the study, mice were fed a high-fat, high-sugar diet to induce obesity, type 2 diabetes, and metabolic dysfunction\u2013associated steatotic liver disease (MASLD)<\/strong>. The mice then received a chronic microdose of psilocybin \u2014 0.05 mg per kilogram of body weight<\/strong> \u2014 over 12 weeks.<\/p>\n\n\n\n

The results were striking.<\/p>\n\n\n\n

Compared to untreated mice, those receiving psilocybin showed:<\/p>\n\n\n\n